abstract: Background: In 2012 the U.S. Food and Drug Administration (FDA) approved the drug emtricitabine/tenofovir for use as Human Immunodeficiency Virus (HIV) pre-exposure prophylaxis (PrEP) after proving to be safe and effective at preventing HIV in multiple peer-reviewed studies. Despite the proven safety and value of PrEP treatment, use remains low in practice. Research has shown that low clinical use corresponds to low levels of understanding of PrEP among providers. Academic detailing is a method of innovation diffusion through provider education that results in changes in knowledge and practice. The purpose of this project was to investigate the effects of academic detailing on primary care provider knowledge, attitudes, and willin...
In 2012, the US Food and Drug Administration approved the pill Truvada for use as pre-exposure proph...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
HIV pre-exposure prophylaxis (PrEP) medication is 99% effective at preventing HIV acquisition if use...
Purpose. This quality improvement project focused on educating primary care providers (PCPs) about p...
The purpose of this project was to improve primary care provider knowledge, attitude and behaviors r...
Human immunodeficiency virus (HIV) is an incurable condition that continues to be a public health th...
Introduction: Approved since 2012 by the Food and Drug Administration, pre-exposure prophylaxis (PrE...
Background: Around 1.2 million people in the United States (U.S.) are currently infected with Human ...
Despite compelling evidence behind the efficacy of pre-exposure prophylaxis (PrEP) in preventing hum...
Introduction: An estimated 1.2 million Americans have indications for using antiretroviral pre-expos...
OBJECTIVES:As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...
Purpose of Project: PrEP decreases a person's chances of contracting HIV by more than 92%. PrEP is a...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
In 2012, the US Food and Drug Administration approved the pill Truvada for use as pre-exposure proph...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
HIV pre-exposure prophylaxis (PrEP) medication is 99% effective at preventing HIV acquisition if use...
Purpose. This quality improvement project focused on educating primary care providers (PCPs) about p...
The purpose of this project was to improve primary care provider knowledge, attitude and behaviors r...
Human immunodeficiency virus (HIV) is an incurable condition that continues to be a public health th...
Introduction: Approved since 2012 by the Food and Drug Administration, pre-exposure prophylaxis (PrE...
Background: Around 1.2 million people in the United States (U.S.) are currently infected with Human ...
Despite compelling evidence behind the efficacy of pre-exposure prophylaxis (PrEP) in preventing hum...
Introduction: An estimated 1.2 million Americans have indications for using antiretroviral pre-expos...
OBJECTIVES:As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...
Purpose of Project: PrEP decreases a person's chances of contracting HIV by more than 92%. PrEP is a...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
In 2012, the US Food and Drug Administration approved the pill Truvada for use as pre-exposure proph...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
HIV pre-exposure prophylaxis (PrEP) medication is 99% effective at preventing HIV acquisition if use...